[go: up one dir, main page]

EE200200102A - Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina - Google Patents

Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina

Info

Publication number
EE200200102A
EE200200102A EEP200200102A EEP200200102A EE200200102A EE 200200102 A EE200200102 A EE 200200102A EE P200200102 A EEP200200102 A EE P200200102A EE P200200102 A EEP200200102 A EE P200200102A EE 200200102 A EE200200102 A EE 200200102A
Authority
EE
Estonia
Prior art keywords
mesoprogestins
hrt
compositions
component
replacement therapy
Prior art date
Application number
EEP200200102A
Other languages
English (en)
Inventor
Elger Walter
Chwalisz Kristof
Schubert Gerd
Original Assignee
Jenapharm Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh & Co. Kg filed Critical Jenapharm Gmbh & Co. Kg
Publication of EE200200102A publication Critical patent/EE200200102A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200102A 1999-08-31 2000-08-31 Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina EE200200102A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38614099A 1999-08-31 1999-08-31
PCT/US2000/023771 WO2001034126A2 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)

Publications (1)

Publication Number Publication Date
EE200200102A true EE200200102A (et) 2003-04-15

Family

ID=23524333

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200102A EE200200102A (et) 1999-08-31 2000-08-31 Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina

Country Status (33)

Country Link
EP (1) EP1605924B1 (et)
JP (1) JP2003513908A (et)
KR (1) KR100729311B1 (et)
CN (1) CN1454088A (et)
AR (1) AR025456A1 (et)
AT (1) ATE413168T1 (et)
AU (1) AU781836B2 (et)
BG (1) BG65846B1 (et)
BR (1) BR0013710A (et)
CA (1) CA2383659C (et)
CO (1) CO5200773A1 (et)
CZ (1) CZ301412B6 (et)
DE (1) DE60040764D1 (et)
EA (1) EA007840B1 (et)
EE (1) EE200200102A (et)
ES (1) ES2316402T3 (et)
HR (1) HRP20020266A2 (et)
HU (1) HUP0202460A3 (et)
IL (2) IL148417A0 (et)
LT (1) LT5011B (et)
LV (1) LV12942B (et)
MX (1) MXPA02002190A (et)
NO (1) NO20021000L (et)
NZ (1) NZ517469A (et)
PE (1) PE20010581A1 (et)
PL (1) PL198798B1 (et)
RO (1) RO122180B1 (et)
RS (1) RS50396B (et)
SI (1) SI20851B (et)
SK (1) SK287121B6 (et)
UA (1) UA75339C2 (et)
WO (1) WO2001034126A2 (et)
ZA (1) ZA200201621B (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
JP2005539016A (ja) * 2002-08-02 2005-12-22 シエーリング アクチエンゲゼルシャフト 女性用受胎調節及びホルモン置換療法のための高められた抗ゴナドトロピン活性を有するプロゲステロン受容体モジュレーター
US20040097591A1 (en) * 2002-11-18 2004-05-20 Kristof Chwalisz Use of selective progesterone receptor modulators for the treatment of androgen deficiency
RU2611370C1 (ru) * 2016-01-12 2017-02-21 Общество с ограниченной ответственностью Медицинская Корпорация "РАНА" Применение препарата Лаеннек для уменьшения или устранения проявления менопаузальных симптомов (варианты)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
DE4225623C2 (de) * 1992-08-03 1994-06-30 Karl Hehl Verfahren zur Herstellung einer pulverförmigen Spritzgußmasse für die Herstellung von Porzellan und deren Verwendung
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
SK283662B6 (sk) * 1994-10-24 2003-11-04 Schering Aktiengesellschaft Kompetetívne progesterónantagonisty na kontrolu samičej fertility zameranú podľa potreby
DE19610635A1 (de) * 1996-03-11 1997-09-18 Schering Ag Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
WO1997049407A1 (en) * 1996-06-25 1997-12-31 Akzo Nobel N.V. Progestogen-anti-progestogen regimens
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
AU2708700A (en) * 1999-01-14 2000-08-01 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents

Also Published As

Publication number Publication date
CO5200773A1 (es) 2002-09-27
PE20010581A1 (es) 2001-06-04
YU14102A (sh) 2006-01-16
LV12942B (en) 2003-06-20
SK287121B6 (sk) 2009-12-07
LT5011B (lt) 2003-04-25
LT2002037A (en) 2002-11-25
NO20021000L (no) 2002-03-14
SI20851A (sl) 2002-10-31
PL353931A1 (en) 2003-12-15
BR0013710A (pt) 2002-05-07
WO2001034126A3 (en) 2001-11-22
RO122180B1 (ro) 2009-02-27
EA007840B1 (ru) 2007-02-27
HUP0202460A2 (hu) 2002-12-28
CA2383659A1 (en) 2001-05-17
NO20021000D0 (no) 2002-02-28
ATE413168T1 (de) 2008-11-15
MXPA02002190A (es) 2002-09-30
BG65846B1 (bg) 2010-03-31
IL148417A0 (en) 2002-09-12
WO2001034126A9 (en) 2002-09-12
AU3633201A (en) 2001-06-06
SK2972002A3 (en) 2002-07-02
DE60040764D1 (de) 2008-12-18
CZ2002706A3 (cs) 2002-10-16
JP2003513908A (ja) 2003-04-15
HRP20020266A2 (en) 2004-08-31
BG106443A (bg) 2002-09-30
EP1605924A2 (en) 2005-12-21
ES2316402T3 (es) 2009-04-16
IL148417A (en) 2010-11-30
AR025456A1 (es) 2002-11-27
WO2001034126A2 (en) 2001-05-17
CZ301412B6 (cs) 2010-02-24
HUP0202460A3 (en) 2004-04-28
NZ517469A (en) 2004-01-30
UA75339C2 (en) 2006-04-17
RS50396B (sr) 2009-12-31
AU781836B2 (en) 2005-06-16
CA2383659C (en) 2009-02-10
EA200200285A1 (ru) 2002-08-29
PL198798B1 (pl) 2008-07-31
KR20020027618A (ko) 2002-04-13
EP1605924B1 (en) 2008-11-05
CN1454088A (zh) 2003-11-05
KR100729311B1 (ko) 2007-06-19
SI20851B (sl) 2009-06-30
ZA200201621B (en) 2004-08-25

Similar Documents

Publication Publication Date Title
ATE432257T1 (de) Tricyclische steroidhormonkernrezeptor- modulatoren
EE200100567A (et) Glükokortikoidretseptori modulaatorid
AU7109000A (en) Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes
UA83620C2 (ru) Замещенные бензоксазолы и их аналоги как эстрогенные агенты
SI1521733T1 (sl) Modulatorji glukokortikoidnega receptorja
NO20010468L (no) Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi
AU2003250935A8 (en) Bile acid derivatives as agonists of the farnesoid x receptor
ATE399163T1 (de) Tricyclische modulatoren von nuklearen steroidhormonrezeptoren
EE200200102A (et) Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina
EE200200103A (et) Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina
DE60210333D1 (de) Tetracyclische heteroverbindungen als modulatoren des östrogenrezeptors
DK1652526T3 (da) Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse
PL372846A1 (en) Non-steroidal progesterone receptor modulators
NO20015378L (no) Cyklokarbamatderivater som progesteronreseptormodulatorer
IL166678A0 (en) 17?-estradiol/levonorgestrel transderm patch for hormone replacement therapy
AU2002353076A1 (en) Antisense modulation of estrogen receptor beta expression
HK1075886A (en) Tricyclic steroid hormone nuclear receptor modulators
AU2002341824A1 (en) Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto
AU2003242849A1 (en) Nuclear hormone receptor
HK1068620A (en) Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
NZ513586A (en) Small molecule modulators of G protein-coupled receptor six

Legal Events

Date Code Title Description
HD1A Correction of address
GB1A Change in the ownership or in the address of the owner
HB1A Correction of owner name or address